HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by volume Browse by article Published Ahead
of Print
 

 

 

If you want to download the journal, please login or register as reader.

2020 Issues

Cover

Vol. 22 • Na. N1 • February 2020

In this issue:

  • Writer's Block Due to Pharmacokinetic Interaction
    Zullino D., and Penzenstadler L.
  • Mood Stabilizing Effects of Methadone in Opioid Use Disorder Patient
    Gohari J., and Riaz U.
  • The impact of affective temperaments on opioid dependence and addiction severity
    Inanli I., Ozturk H.I., Caliskan A.M., Ozbek S., Demirel B., Er M., and Eren I.
  • Stigma against pregnant women addicted to opioids with a case report
    Mehić-Basara N., Marjanović-Lisac S., and Grabovica M.
  • High prevalence and risks factors for non-communicable diseases in older people with opioid use disorder.
    Vallecillo G., Robles M.J., Duran X., Castillo C., Fonseca F., and Torrens M.
  • Is the Treatment Long Enough? Associations Between Quality of Life and Treatment Duration in Methadone Maintenance Treatment
    Chen Y.-A., Yen T.-T., Hsu W.-Y., Chang T.-G., Chang Y.-J., Chiu N.-Y., and Chang C.-C.
  • Nearly thirty years of experience of real-world long-term treatment with Opioid Agonists
    Lamanna F., Maremmani A.G.I., and Maremmani I.

 

Cover

Vol. 22 • Na. N2 • April 2020

In this issue:

  • Mapping service user needs to inform a supervised Injecting room location in Cork, Ireland, EU
    Horan J.A., and Van Hout M.C.
  • Is there a correlation between vitamin D deficiency and low serum level of GDNF in substance use disorder cases?
    Alipour M., Jafarian M., Mokri A., Gorji A., Zarindast M.R., Kargar Kheirabad A., and Razaghi E.M.
  • Buprenorphine for the treatment of alcohol dependence: 14 attempts, 3 successful cases
    Ulmer A., and Meinhold C.
  • Assessing the Medical and Psychological Problems Faced by ‘Majun-e-falak Sair' Addicts
    Jan S.U.K., Ali A., and Asad A.Z.
  • A prospective study of psychopathology stability and changes after 3-month residential treatment in Italian Substance Use Disorder patients
    Maremmani I., Iantomasi C., Pani P.P., Maremmani A.G.I., and Mathis F. for the VOECT Group

 

Cover

Vol. 22 • Na. N3 • June 2020

In this issue:

  • Hepatitis C Related Mortality in a Cohort of Drug Users in Flanders
    De Ryck H., and Matheï C.
  • Extent and Trend of Prescription Opioids in Assisted Treatment Programmes for Opioid Addiction and Pain Medications in Slovenia from 2007 until 2018
    Kostnapfel T., Korosec A., and Kastelic A.
  • Children's Psychological Well-Being, Anxiety, Depression, and Stress: The Role of Addicted and Non-Addicted Parents
    Moeenizadeh M., Anbarani B., and Asghari Ebrahimabad M.J.
  • Association of Serum Leptin Level with Body Mass Index and Lipid Profile in Diacetylmorphine (Heroine) Addicts Versus Healthy Controls.
    Habib S.H., Khizar S.H., Malik M.O., Tariq M., Ramzan M.H., and Khan M.K.
  • Prominent Psychopathological and Clinical Characteristics of Heroin Post-Traumatic Stress Disorder Spectrum Patients During Treatment
    Maremmani I., Cecchini L., Avella M.T., Novi M., Ciapparelli A., and Maremmani A.G.I.

 

Cover

Vol. 22 • Na. N4 • August 2020

In this issue:

  • Dermatological and Psychiatric Manifestations in Heroin and Bonsai Use Disorder
    Can Y., Kıvanç Altunay İ., Mercan S., Evren C., Poşpoş Ö.H., and Özkur E.
  • Medical Adjustment of Alcohol Dependence – a Comparison of Treatment Results with Dihydrocodeine and Acamprosate
    Ulmer A., Frietsch B., and Mueller M.
  • Frequency Rate of Violence and Contributing Factors in Methadone Maintenance Treatment Centers in Tehran, Iran
    Kheradmand A., Iliaiee S., Ghafari Nejad A., and Mashayekhi M.M.
  • Harm Reduction 24/7: Evaluation of the Vending Machine Program for Drug Users in North Rhine-Westphalia, Germany.
    Deimel D., Felix O., Bock C., and Stöver H.
  • The Psychopathology Specific to Substance Use Disorder Is Able to Discriminate between Young People with and without Problematic Internet Use
    Maremmani A.G.I., Cerniglia L., Cimino S., Maiello M., Della Rocca F., and Maremmani I.

 

Cover

Vol. 22 • Na. N5 • October 2020

In this issue:

  • Can the Psychopathology Specific to Substance Use Disorder Distinguish between Reward and Relief Craving?
    Maremmani A.G.I., Pallucchini A., Manni C., Cipollone G., Della Rocca F., Salarpi G., Perugi G., and Maremmani I.
  • Tramadol as the Most Prescribed Opioid Analgetic Medication in Slovenia in Recent Years
    Kostnapfel T., Korošec A., and Kastelic A.
  • Sleep Quality in Heroin-Dependent Patients Undergoing Three Types of Maintenance Therapy: The Benefits Promised by Opium Tincture Maintenance Therapy
    Hojjat S.K., Kaviyani F., Akbari H., and Norozi Khalili M.
  • The TALS – Reduced Form: An Inventory for Assessing the Heroin Post-Traumatic Stress Disorder Spectrum (H/Ptsd-S)
    Maremmani I., and Miccoli M.
  • Depression Resistant to Antidepressant Medications or Depression Complicated by Hypophoria? A Case Report
    Paganin W., Signorini S., and Maremmani I.
  • Methadone as a Treatment Option for Restless Leg Syndrome in Opioid Use Disorder Patient.
    Riaz U.

 

Cover

Vol. 22 • Na. N6 • December 2020

In this issue:

  • "Bursting the Lyrica Bubble”: Experiences of Pregabalin Use in Individuals Accessing Opioid Agonist Treatment in Dublin, Ireland
    Brennan R., and Van Hout M.C.
  • The Association between Somatic Complaints and Past-30 Day Opioid Misuse among Justice-Involved Children
    Johnson M.E., and Clerjuste S.
  • Predicting Craving Beliefs through Abstinence Self-Efficacy Components
    Farzin M.M., and Abed M.
  • Anti-Hcv Treatment for Opiate Addicts: Clinical and Immunological Issues
    Occhino G., Somaini L., Maremmani I., Maremmani A.G.I., Boccato E., Pirisi M., and Pacini M.
  • Is the Non-Medical Use of Pregabalin Related to Reward/Relief Craving Coupled to an Unbalanced Opioid System?
    Della Rocca F., Cosentino V., Carbone M.G., Maremmani A.G.I., and Maremmani I.
  • Is the Psychopathology Specific of Substance Use Disorder Able to Differentiate Problematic and Non-Problematic Recreational Drinkers?
    Pagni L., Conversano C., Miccoli M., Maremmani A.G.I., Pani P.P., and Maremmani I.
  • Toward Patient-Tailored Therapy in Agonist Opioid Treatment: The Role of Psychopathology, Craving Behavioural Covariates, Stress Reaction and Methadone Blood Concentration. A Case Series
    Maremmani A.G.I., Bacciardi S., Maremmani I., Della Rocca F., Lamanna F., Socci C., Cerrai E., Zallocco L., Cerniglia L., Cimino S., Giusti L., Lucacchini A., Protti M., Mercolini L., Perugi G., and Mazzoni M.R.

 

 

AU-CNS Associazione per l’Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali
Association for the Application of Neuroscientific Knowledge to Social Aims
Via XX Settembre, 83 – 55045 PIETRASANTA (Lucca) - Italy
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page